Your browser doesn't support javascript.
loading
Inflammation is predictive of outcome in Waldenström macroglobulinemia treated by Bruton tyrosine kinase inhibitors: a multicentric real-life study.
Debureaux, Pierre-Edouard; Forgeard, Nathalie; Elessa, Dikelele; Harel, Stéphanie; Frenzel, Laurent; Royer, Bruno; Talbot, Alexis; Choquet, Sylvain; Davi, Frederic; Nguyen-Khac, Florence; Cuccuini, Wendy; Cheminant, Morgane; Bravetti, Clotilde; Lazarian, Gregory; Kaltenbach, Sophie; Hermine, Olivier; Roos-Weil, Damien; Espéli, Marion; Balabanian, Karl; Arnulf, Bertrand.
Afiliação
  • Debureaux PE; INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris, France; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris. Pierre-edouard.debureaux@aphp.fr.
  • Forgeard N; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris, France; Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris.
  • Elessa D; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris.
  • Harel S; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris.
  • Frenzel L; Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris.
  • Royer B; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris.
  • Talbot A; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris.
  • Choquet S; Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris.
  • Davi F; Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris.
  • Nguyen-Khac F; Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris, France; Centre de Recherche des Cordeliers, Sorbonne Université, Université Paris Cité, Inserm UMRS1138, Drug Resistance in Hematological Malignancies Team, Paris.
  • Cuccuini W; Laboratory of Cytogenetic, Hospital Saint Louis, Assistance Publique Hopitaux de Paris, Paris.
  • Cheminant M; Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris.
  • Bravetti C; Laboratory of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris.
  • Lazarian G; Laboratory of Hematology, Hospital Avicenne, Assistance Publique Hopitaux de Paris, Paris.
  • Kaltenbach S; Laboratory of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris.
  • Hermine O; Department of Hematology, Hospital Necker, Assistance Publique Hopitaux de Paris, Paris.
  • Roos-Weil D; Sorbonne Université, Department of Hematology, Hospital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris.
  • Espéli M; INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris.
  • Balabanian K; INSERM U1160 EMiLy, Institut de Recherche Saint-Louis, Université Paris-Cité, Paris.
  • Arnulf B; Department of Immuno Hematology, Hospital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris, France; University of Paris Cité, Paris. Bertrand.arnulf@aphp.fr.
Haematologica ; 109(1): 325-330, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37584289
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Macroglobulinemia de Waldenstrom Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article